Navigation Links
Millions Around the World to Have Access to Low-Cost HIV Test by 2013

MELBOURNE, Australia, June 20, 2012 /PRNewswire/ -- For the first time, HIV patients in developing countries will have access to an affordable diagnostic test to determine if they should start life-saving antiretroviral drugs.

The Burnet Institute in Melbourne has announced a licensing agreement with Omega Diagnostics Group PLC, a global diagnostics organisation, to commercialise the point-of-care CD4 test for use worldwide, including aid agencies delivering frontline health services.

Omega has manufactured a first small-scale batch of prototype devices but reports there is still further work to do in terms of manufacturing scale-up and field trial evaluations before the first commercial sale of product. The company will host the commercial launch of the POC CD4 test at the 19th International AIDS Conference, AIDS 2012, to be held in Washington DC from 22-27 July.

Burnet Institute Deputy Director, Associate Professor David Anderson developed the low-cost test along with Co-head of Burnet's Centre for Virology Professor Suzanne Crowe AM.

"According to UNAIDS, there are 15 million people who should be getting access to antiretroviral therapy but aren't, just because they can't get access to an affordable CD4 test in their communities," Associate Professor Anderson said.

The CD4 test uses a small amount of blood from a finger-prick with results available after 40 minutes at a cost significantly less than the existing tests.

Current tests to determine CD4 cell count cost more than AUD $10. It requires trained health workers to collect venous blood and highly trained technicians to perform the tests on expensive equipment requiring power, clean water and regular maintenance.

"It's easy to diagnose HIV but it's hard to identify those who need therapy, this test will change that, providing cost effective testing for up to 33 million patients worldwide," Professor Anderson said.

Aid agencies in Papua New Guinea, India and South Africa are likely to be among the first to access the Burnet CD4 test.

This is the culmination of six years work by Associate Professor Anderson, Professor Crowe AM, Mary Garcia, Nadine Barnes, Simone Van de Waarsenburg, Jocelyn Diaz, Robyn Lloyd and Joy Liu at Burnet. It was also developed in collaboration with Professor Alan Landay from Rush University in Chicago and Professor Thomas Denny from Duke University in North Carolina.

To arrange an interview with Associate Professor David Anderson please contact:
Catherine Somerville
Media and Communications Officer, Burnet Institute
Ph: +61 422 043 498 or email:  

SOURCE Burnet Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
2. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
3. Ophthalmic Drugs: World Market Prospects 2012-2022
4. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
5. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
6. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
7. Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
8. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
9. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
10. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
11. DebMed® to Debut Benefits of Worlds First Electronic Hand Hygiene Compliance Monitoring System Using the WHO Five Moments at Annual Infection Control Conference
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015   Nottingham Spirk , ... announced the publication of a free whitepaper ... Medical Market". The whitepaper gives medical product companies, ... penetrating this lucrative segment. Nottingham Spirk ... to manage their own health, save money (i.e., ...
(Date:12/1/2015)... BOULDER, Colo. , Dec. 1, 2015 ... ARRY ) today announced that its Chief ... present at the Oppenheimer Annual Healthcare Conference ... to participate in the conference through a ... , --> ...
(Date:12/1/2015)... BANGALORE, India and ... (NASDAQ, TASE: MYL) today announced that it expects to ... for developing country markets funded by international donors, TLE400 ... + Efavirenz 400 mg) for $99 per patient, per ... (CHAI) to develop TLE400. The significantly reduced price could ...
Breaking Medicine Technology:
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken at ... accurate interpretation by the radiologist. The marking utensils are so small, however, they ... found a way to alleviate this problem. , He developed the patent-pending MARK ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
Breaking Medicine News(10 mins):